Prescription Drug Abuse | Behavioral Healthcare Executive Skip to content Skip to navigation

Prescription Drug Abuse

DEA operation flags 26 potentially rogue pharmacies

December 6, 2017  |  Tom Valentino, Senior Editor
news

An operation conducted by the DEA’s Los Angeles field division has identified 26 pharmacies in southern California, Hawaii and Nevada that are suspected of violating the Controlled Substances Act.

DEA creates Kentucky field division

November 29, 2017  |  Julie Miller, Editor in Chief
article

On Wednesday, the Drug Enforcement Administration (DEA) announced the establishment of a new DEA Field Division in Louisville, Ky.

Doctors make big money testing urine for drugs, then ignore abnormal results

November 29, 2017  |  Kaiser Health News
news

In nearly a dozen recent criminal cases, prosecutors have cited evidence that doctors supplied opiates to patients with repeated abnormal urine test results.

Cost analysis backs immediate access to agonist drugs for opioid dependence

November 29, 2017  |  Gary A. Enos, Contributing Editor
article

A cost-effectiveness analysis using California data makes a strong case for significant public investment in methadone and buprenorphine treatment.

Massachusetts governor unveils $110 million opioid bill

November 27, 2017  |  Tom Valentino, Senior Editor
article

Massachusetts Governor Charlie Baker has introduced legislation designed to improve addiction treatment standards and allow doctors to commit unwilling patients to 72 hours in a treatment facility.

Big Pharma, big lawsuits

November 22, 2017  |  Brian Albright
article

The claimants in most of the pharma lawsuits want to see an end to what they characterize as aggressive and misleading opioid marketing as well as help in shouldering the enormous cost to states, counties and cities now dealing with overdose deaths.

Opioid crisis update from the field

November 9, 2017  |  Ron Manderscheid, PhD, Exec Dir, NACBHDD and NARMH
blog

This week’s 2017 National Meeting of the American Public Health Association featured almost a dozen sessions on today’s opioid crisis. My commentary today seeks to provide an overview of where we currently stand in our national efforts to address this profound...

Florida insurer to cease OxyContin coverage

November 8, 2017  |  Tom Valentino, Senior Editor
news

Florida Blue announced it will cease coverage of OxyContin by January, following in the footsteps of Cigna.

Record-setting amount of prescriptions collected on Take Back Day

November 7, 2017  |  Tom Valentino, Senior Editor
news

More than 456 tons of unwanted medications were collected for safe disposal during the U.S. Drug Enforcement Administration’s 14th Prescription Drug Take Back Day.

Would involuntary commitment for addiction save lives?

November 2, 2017  |  Jill Sederstrom
article

Civil commitment for those who need addiction treatment could save lives, but hurdles impede implementation as states work through legal and ethical concerns.

IMD changes trump emergency declaration

October 26, 2017  |  Tom Valentino, Senior Editor
article

In addition to declaring the opioid crisis a public health emergency, President Donald Trump on Thursday announced a policy to expedite the waiver process for states requesting an IMD exclusion workaround.

Opioid crisis made worse by big-money influence and DEA disablement

October 17, 2017  |  Julie Miller, Editor in Chief
article

Those who are working tirelessly to address the opioid crisis were disheartened by a recent report that describes how profitable drug distributors influenced a policy that reduced the DEA’s ability to stop diversion.

Pages

Subscribe to Prescription Drug Abuse